Originally published In Press as doi:10.1074/jbc.M205783200 on August 19, 2002
J. Biol. Chem., Vol. 277, Issue 43, 41023-41031, October 25, 2002
Significance of GTP Hydrolysis in Ypt1p-regulated Endoplasmic
Reticulum to Golgi Transport Revealed by the Analysis of Two Novel
Ypt1-GAPs*
Anna
De Antoni
,
Jana
Schmitzová,
Hans-Heinrich
Trepte,
Dieter
Gallwitz§, and
tefan
Albert¶
From the Max-Planck-Institute for Biophysical Chemistry, Department
of Molecular Genetics, D-37070 Göttingen, Germany
Received for publication, June 11, 2002, and in revised form, August 9, 2002
 |
ABSTRACT |
We here report on the identification and detailed
biochemical characterization of two novel GTPase-activating proteins,
Gyp5p and Gyp8p, whose efficient substrate is Ypt1p, a Ypt/Rab-GTPase essential for endoplasmic reticulum-to-Golgi trafficking in yeast. Gyp5p accelerated the intrinsic GTPase activity of Ypt1p 4.2 × 104-fold and, surprisingly, the 40-fold reduced GTP
hydrolysis rate of Ypt1(Q67L)p 1.5 × 104-fold. At
steady state, the two newly discovered GTPase-activating proteins
(GAPs) as well as the previously described Gyp1p, which also uses Ypt1p
as the preferred substrate, display different subcellular localization.
To add to an understanding of the significance of Ypt1p-bound GTP
hydrolysis in vivo, yeast strains expressing the
GTPase-deficient Ypt1(Q67L)p and having different Ypt1-GAP genes
deleted were created. Depending on the genetic background, different
mutants exhibited growth defects at low temperature and, already at
permissive temperature, various morphological alterations resembling
autophagy. Transport of proteins was not significantly impaired. Growth
defects of Ypt1(Q67L)-expressing cells could be suppressed on high
expression of all three Ypt1-GAPs. We propose that permanently active
Ypt1p leads to increased vesicle fusion, which might induce previously
unnoticed autophagic degradation of exaggerated membrane-enclosed
structures. The data indicate that hydrolysis of Ypt1p-bound GTP is a
prerequisite for a balanced vesicle flow between endoplasmic reticulum
and Golgi compartments.
 |
INTRODUCTION |
In eukaryotic cells, a large number of newly synthesized
proteins and of proteins internalized from the plasma membrane pass through membrane-enclosed compartments to reach their final
destination. Transport between organelles of the biosynthetic and the
endocytic pathway involves vesicular intermediates that fuse with
specific target compartments to deliver their cargo (1). Transport
vesicle formation and targeting require complex molecular machines, and different Ras-like GTPases act as key regulators in assembling specific
protein complexes at different donor and target membranes (2-4).
Genetic and in vitro transport studies in yeast indicate that Ypt/Rab-GTPases act in tethering transport vesicles to their cognate acceptor membranes before
SNARE1 pairing (5, 6), but
the molecular details of GTPase function are still unresolved. Of the
11 yeast Ypt/Rab family members, only the ones involved in the
secretory pathway are essential for cell viability (7). Among them is
Ypt1p, the regulator of forward transport between the ER and the Golgi.
Ypt1p appears to exert its vesicle tethering function when bound to the
target membrane of early Golgi compartment(s) (8).
Since Ypt/Rab-GTPases, like Ras, cycle between an active, GTP-bound and
an inactive, GDP-bound conformation, GDP-GTP exchange by specific
exchange factors (guanine nucleotide exchange factors) and
hydrolysis of the bound GTP catalyzed by GTPase-activating proteins
(GAPs) are expected to play important roles in the functioning of these
proteins. The hydrolysis of GTP has been associated with either the
membrane fusion process itself, with the recycling of the GTPases, or
with the role of the GTPase as a timer for membrane fusion (9, 10). In
a perhaps extreme view, it has even been argued that, in the case of
Ypt1p, GTP hydrolysis is not important for the protein's function in
vesicular transport (11). Although Ypt/Rab- GTPases possess a slow
intrinsic GTPase activity, which in most cases is significantly slower
than 0.01 min
1 at 30 °C (12), effective
down-regulation of the regulators requires specific GTPase-activating proteins.
The first Ypt/Rab-specific GAPs, termed Gyp (GAP for
Ypt proteins), were isolated from yeast by high
expression cloning (13-15). It was subsequently noted that these GAPs
contained regions of sequence similarity with many proteins of unknown
function from yeast and higher eukaryotes (16). This was also helpful
for the identification and cloning of other Ypt/Rab-GAPs from yeast (17-20). So far, six related GAPs from Saccharomyces
cerevisiae constitute a protein family that we have termed GYP.
Most of the yeast Ypt/Rab-GAPs have a rather broad substrate
specificity, but all of them are highly active, accelerating the
intrinsic GTP hydrolysis rate of their preferred substrates
104- to 106-fold. Among the six known Gyp
proteins, only Gyp1p efficiently uses Ypt1p as substrate in
vitro, but this GAP accelerates the intrinsic GTPase activities of
Ypt51p, Sec4p, and Ypt7p with similar efficiency (18, 20). The
overlapping substrate specificity of GYP family members might explain
why the chromosomal deletion of individual GYP genes is
phenotypically neutral. Concerning ER-to-Golgi transport, it was also
possible that additional Ypt1-GAPs might participate in the regulation
of Ypt1p activity.
We have now isolated two novel GYP genes whose protein products, Gyp5p
and Gyp8p, are potent Ypt1-GAPs. Whereas Gyp5p has a remarkable
specificity for Ypt1p in vitro, Ypt6p, which appears to be
functionally linked to Ypt1p
(21),2 is the preferred
substrate for Gyp8p. We now find that Ypt1(Q67L)p, unlike the
equivalent mammalian Ras(Q61L) mutant protein, served as efficient
substrate for Gyp5p, explaining, at least in part, why previous studies
using the ypt1Q67L mutant allele did not cause major
phenotypic alterations in some yeast strains (11). Synthetic growth
defects and morphologically prominent alterations in mutants with a
combination of the ypt1Q67L mutant allele and
Ypt1-GAP gene deletions, which we describe here, demonstrate that
hydrolysis of Ypt1p-bound GTP is in fact required for effective
functioning of this regulatory GTPase.
 |
EXPERIMENTAL PROCEDURES |
Yeast Strains, Cell Growth, and Genetic Techniques--
S.
cerevisiae strains cl3-ABYS-86 (MAT
ura3-5 leu2-3 112 his3 pra1-1
prb1-1 prc1-1 cps1-3
canR) from D. H. Wolf (University of Stuttgart,
Germany) and MSUC-3D (MAT
ura3 trp1 leu2 his3
lys2) (this laboratory) were used for further genetic
manipulations. For expression and purification of potential GAPs, the
protease-deficient yeast strain BJ5459 (MATa
ura3 leu2 his3 lys2 pep4::HIS3 prb1D.16R
kan1), originally obtained from the Yeast Genetic Stock Center,
University of California, Berkeley, was employed. To analyze growth of
different strains at various temperatures, logarithmically growing
cultures were diluted into fresh YPD medium (1% yeast extract, 2%
peptone, 2% dextrose) to an optical density of
A600 ~0.01. From serial 10-fold dilutions, 4 µl each were spotted onto YPD-agar plates, and cells were grown at
the appropriate temperatures. Cell growth in liquid cultures was
followed by measuring the optical density at 600 nm, and the
duplication time was calculated from the exponential parts of the
growth curves.
Gene deletions were performed by replacement with
loxP-KanMX-loxP cassettes (22); carboxyl-terminal epitope
tagging was as described by De Antoni and Gallwitz (23). Replacement of the YPT1 gene on chromosome VI with the mutant
ypt1Q67L gene was achieved by transforming relevant
yeast strains with the linearized vector pREypt1Q67L as
previously described (24).
Cloning of GYP Genes--
Open reading frames YPL249c
(GYP5) and YFL027c (GYP8) were amplified by high
stringency PCRs using proofreading DNA polymerases (12). Forward
primers started with the translation initiation codon (boldface type)
and had a 5' overhang with restriction enzyme recognition sequences
(underlined). Reverse primers contained six consecutive histidine
codons in front of the translational stop codon: GYP5-forward,
5'-CATGGATTCCATATGTCTTCATCAGACAAATCTATTG-3'; GYP5-reverse,
5'-ACGGCTAGCGTCGACTTAATGGTGATGGTGATGGTGTTTAAAAACTTTTTTAAAACCAGTC-3'; GYP8-forward,
5'-ATCAGATCTCATATGCCATTAAGGTCATTATTTC-3'; GYP8-reverse,
5'-GTACTCGAGAAGCTTAGTGATGGTGATGGTGATGTCTAGTTGGATGCCCCAG-3'.
GYP5 PCR products were cleaved with BamHI and
NheI and ligated into
BamHI-XbaI-cleaved pYES2 plasmid (Invitrogen).
GYP8 PCR products were cleaved with NdeI and XhoI
and ligated into pET22a (Novagen) cleaved with the same enzymes.
Truncated genes were created by cloning the appropriate PCR
products as described above and ligation into pET30a (Novagen).
Suppression analysis of yeast mutants was done with
GYP genes cloned under TPI promoter control in the
2µ-based vector pYX212 (R & D Systems).
Subcellular Fractionations, Protein Blots, and Fluorescence
Microscopy--
Subcellular fractionation by differential
centrifugation and the preparation of yeast cell extracts for
immunological protein detection were as described previously (26).
Proteins in SDS-PAGE-fractionated extracts were detected
immunologically after electrotransfer onto nitrocellulose membranes
(Schleicher & Schuell) and incubation with appropriately diluted
anti-VSV epitope antibodies (Roche Molecular Biochemicals). Gyp-GFP
fusions were prepared by cloning of BamHI- plus
SalI-cleaved GYP genes (recognition sequences
were included in the PCR primers) into pUG23 vector (27). For YFP-CFP double fluorescence studies, pUG23 was modified by replacing the GFP
gene with YFP or CFP. YFP and CFP genes were obtained by PCR from vectors pEYFP and pECFP (CLONTECH),
respectively. For coexpression of GYP1-YFP and GYP8-CFP, the GYP8-CFP
expression cassette was transplanted from pUG23-GYP8-CFP
(HIS3 marker) into URA3-marked vector pUG36 (27).
Double transformants were grown in selective medium lacking both
histidine and uracil and analyzed by confocal fluorescence microscopy
using Leica TCSSP2. Fluorescent data were recorded at CFP- and
YFP-specific excitation and emission wavelengths. Records at different
wavelengths were merged using Photoshop 5.5 software.
Expression and Purification of Recombinant
Proteins--
Ypt-GTPases were expressed from pET vectors in E. coli BL21(DE3) (Novagen) and purified by anion exchange
chromatography and gel filtration (28). Bacterially expressed,
catalytically active Gyp5-58p and Gyp8-49p, His6-tagged
at their C termini, were affinity-purified on
Ni2+-nitrilotriacetic acid-agarose (Qiagen) and further
purified by ion exchange chromatography on MonoQ HR10/10 (Amersham
Biosciences) and by gel filtration using Sephacryl S-200 HR 16/60. The
purification method described (12, 18) was modified in that 1% of
Triton X-100 (Baker) was included in the cell lysis buffer to
facilitate protein solubility. If required, purified proteins were
concentrated by ultrafiltration using Microsep (Pall Filtron
Corp.).
Biochemical Analysis of GAPs--
Filter GAP assays using
[
-32P]GTP (PerkinElmer Life Sciences) were performed
as described (14). HPLC-based GAP assays were performed exactly as
previously described (12). For determining the extremely low intrinsic
hydrolysis rates of Ypt1(Q67L)p mutant protein, the incubation time at
30 °C was extended over 8 h. The biochemical properties of
Gyp5p with Ypt1p and Ypt1(Q67L)p as substrates were determined using an
integrated Michaelis-Menten procedure (29) as described (18). Due to
the extremely slow intrinsic GTP hydrolysis rate of Ypt1(Q67L)p, rates
of the GAP-accelerated reactions were followed using fixed
concentrations of the mutant GTPase (10 and 20 µM,
respectively, for the Gyp5p- and Gyp8p-catalyzed reaction) and
excessive amounts of the two GAPs.
Electron Microscopy--
To augment intracellular membranes,
yeast cells were fixed with potassium permanganate and processed for
electron microscopy as described previously (26).
 |
RESULTS |
Identification of Two Novel Ypt/Rab-specific
GAPs--
Six moderately conserved sequence segments constitute the
GYP domain of the catalytically active region of Ypt/Rab-specific GAPs.
Within this region of the biochemically identified GAPs, six from yeast
and two from mammals, there are three absolutely conserved "GYP
fingerprint" sequences, RXXXW,
IXXDXXR, and YXQ (Fig.
1A), which are helpful to
identify members of this class of proteins. Using this criterion, two
other yeast proteins, encoded by the reading frames YPL249c and
YFL027c, were predicted to be members of the GYP family. The genes were
amplified by PCR from total S. cerevisiae DNA and expressed
from a multicopy vector as C-terminally His6-tagged
proteins in yeast. Proteins adsorbed to Ni2+-agarose were
first tested for GAP activity with different GTP-loaded Ypt-GTPases in
a standard assay (12). We found that the protein product of YPL249c,
hereinafter termed Gyp5p, accelerated the intrinsic GTP hydrolysis rate
of Ypt1p significantly and that of Sec4p marginally. High expression
and purification of full-length YFL027c protein was not successful
either in yeast or in Escherichia coli. Because our previous
studies (18) had shown that deletion of sequences outside the catalytic
domain can result in improved yield and solubility of bacterially
produced Ypt-GAPs, short C-terminal truncations of 33 and 77 amino
acids, respectively, were made of the YFL027 protein. The larger
truncation was found to allow easy production in E. coli of
soluble protein with GAP activity toward Ypt1p and Ypt6p. The gene
comprising the reading frame YFL027c was therefore designated
GYP8.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 1.
Sequence comparison of the Ypt1-GAPs Gyp1p,
Gyp5p, and Gyp8p and truncations of Gyp5p to identify its catalytic
domain and suppressor activity. A, protein sequence
alignments were done with ClustalW and edited manually. The six
conserved motifs (16), which form the core of the Gyp1 catalytic domain
(32), are indicated by blue bars. The conserved amino acids of
the GYP "fingerprint" sequences are highlighted by a red
background, and the invariant arginine residue required for
catalysis is indicated by a star. B, schematic
representation of Gyp5p and its different truncations. The GYP domain
is indicated by a blue box. Proteins were tested
for GAP activity with GTP-loaded Ypt1p using an HPLC-based assay and
for suppressing activity of a cold-sensitive
ypt1Q67L strain. ND, not
determined.
|
|
As shown in Fig. 1, the GYP domain of the 101.6-kDa Gyp5p is localized
in the C-terminal half of the protein (amino acids 451-624), whereas
in the 57.6-kDa Gyp8p it occupies most of the N-terminal half (amino
acids 68-275). Gyp5p harbors a coiled-coil region of about 140 amino
acid residues at its C terminus and a serine- and proline-rich domain
located N-terminally of the GYP domain. In correspondence with
mutational studies of Gyp1p and Gyp7p (18), we observed that deletion
of the large N-terminal region preceding the GYP domain of Gyp5p did
not affect its GAP activity and that a larger sequence segment
following the GYP domain was required for the protein's catalytic
activity. However, at least 135 amino acids could be removed from the
C-terminal end of Gyp5p without interfering with its GAP activity (Fig.
1B).
Gyp5p and Gyp8p Are Potent GAPs for Ypt1p--
For the biochemical
characterization, a 493-amino acid-long fragment of Gyp5p (Gyp5-58p,
residues 400-892) and a 420-amino acid-long Gyp8 protein lacking only
the C-terminal 77 residues (Gyp8-49p) were produced in E. coli and purified by affinity and ion exchange chromatography
and by gel filtration. Our previous studies had shown that various
biochemical parameters, like substrate specificity and activation
rates, did not change significantly when full-length and truncated
active Gyp proteins were compared (18). We first inquired into the
substrate specificity of the novel GAPs employing a quantitative
HPLC-based method to compare the GAP activity with different GTP-loaded
GTPases (12). As shown in Table I,
Gyp5-58p exhibited a clear preference for Ypt1p over Sec4p, the only
other GTPase whose intrinsic GTPase activity was accelerated by this
GAP. For Gyp8-49p, which had a higher specific activity than Gyp5-58p
(Fig. 2A), Ypt1p and Ypt6p
were the most efficient substrates (Table I). Although in the standard assay, the acceleration of the intrinsic GTP hydrolysis rate was higher
for Ypt6p due to its extremely slow intrinsic GTPase activity, in
absolute terms the reaction rate with Ypt1p (k = 1.144 min
1) was higher than that with Ypt6p (k = 0.385 min
1). In addition, Sec4p and, less pronounced,
the redundant GTPases Ypt31p and Ypt32p served as substrate for
Gyp8-49p in vitro.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
Ypt1p is substrate for both Gyp5-58p and
Gyp8-49p. A, Ypt1p·GTP complex (20 µM) was
incubated with buffer (intrinsic), 0.2 µM Gyp5-58p, 0.2 µM Gyp5-58(R496A)p, or 0.02 µM Gyp8-49p.
Ypt1p-bound GTP and GDP were determined by HPLC analysis. Whereas wild
type Gyp proteins accelerate GTP hydrolysis efficiently, Gyp5(R496A)p
is almost completely inactive. B, Ypt1p·GTP complex (120 µM) was incubated at 30 °C with 0.6 µM
Gyp5-58p, and the extent of GTP hydrolysis was determined by HPLC. The
concentration of Ypt1p·GTP was plotted as a function of time and
fitted by an integrated Michaelis-Menten equation.
|
|
In further experiments, we studied the interaction between Gyp5-58p
and its preferred substrate Ypt1p and determined the GAP catalytic
activity and the substrate affinity from single time curves by means of
an integrated Michaelis-Menten equation (18, 29, 30) (Fig.
2B). In a reaction with a 200-fold excess of Ypt1p·GTP
over Gyp5-58p, we determined kcat to be 106 min
1, which corresponds to a 4.24 × 104-fold acceleration of the intrinsic hydrolysis rate of
this GTPase. With a Km of 74.5 µM,
Gyp5-58p, like other Ypt-GAPs (18, 19, 31), has a low affinity for its
preferred substrate GTPase Ypt1p. So far, kcat
and Km for Gyp8-49p could not be determined with
certainty, since under the experimental conditions of the HPLC-based
GAP assay, increasing substrate concentrations tended to inhibit GAP activity.
One of the structural hallmarks of Ypt-GAPs is a conserved arginine
within the IXXDXXR sequence motif (Fig.
1A). This residue is critical for GAP catalytic function
(18, 31), and the three-dimensional structure of Gyp1p (32) indicates
that it might act in catalysis like the "finger arginine" of
Ras-GAP (33). We have substituted this arginine with either alanine or
lysine in both Gyp5p (Arg496) and Gyp8p
(Arg114) and found that each of the four mutant proteins
almost completely lost GAP activity (shown for Gyp5p in Fig.
2A).
Intracellular Distribution of Gyp5p and Gyp8p--
Of the eight
Gyp family members in yeast, three (Gyp1p (18, 34), Gyp5p, and Gyp8p
(this report)) are now known to be potent GAPs in vitro for
Ypt1p, the GTPase with an essential function in ER-to-Golgi transport.
In a recent report (34), fluorescence microscopic data were presented
showing that on high expression, red fluorescent protein-tagged Gyp1p
partially colocalized in punctate structures with a GFP fusion of the
Golgi protein Bet3p, suggesting Golgi association of Gyp1p. In a first
attempt to assign Gyp5p and Gyp8p to their main cellular compartment(s)
and to determine the relative abundance of the three Ypt1-GAPs, Gyp5p,
Gyp8p, and Gyp1p were C-terminally tagged with VSV, MYC, or
hemagglutinin epitopes and expressed from the modified genes that were
integrated into the genome of the protease-deficient strain Cl3-ABYS-86
such that they replaced the respective chromosomal wild type copies. This experimental procedure was chosen to also avoid possible artifacts
resulting from unphysiologically high intracellular concentration of
the GAPs. The relative abundance of the three GAPs was calculated from
immunoblots of electrophoretically separated total cellular proteins
performed with antibodies specific for the protein tags. Fig.
3 shows an immunoblot with VSV-tagged
Ypt-GAPs, which was subjected to quantification of the reactive protein bands using a Lumi-Imager. According to these analyses, the
intracellular levels of Gyp5p and Gyp1p were about 12.5 and 6 times
higher, respectively, than that of Gyp8p. In subcellular fractionation experiments, Gyp1p was distributed almost equally between the P10,
P100, and soluble fractions. In contrast, Gyp5p was in the soluble
fraction nearly exclusively. Gyp8p was enriched in the P10 fraction,
suggesting that a significant portion was either part of large protein
complexes or associated preferentially with the ER and/or the plasma
membrane (data not shown).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 3.
Relative abundance of Ypt1-GAPs. The
reading frames of GYP1, GYP5, and GYP8
in their normal chromosomal environments were extended with three
consecutive VSV epitope tags. Logarithmically growing cells expressing
the three modified GAPs were subjected to alkaline lysis and
immunoblotting. Two preparations were probed with anti-VSV antibody for
each protein. Signal intensities were quantified with a
Lumi-Imager.
|
|
The intracellular distribution of the three Ypt1-GAPs was also
studied by fluorescence microscopy using C-terminal GFP fusions. In
agreement with the cell fractionation data, the Gyp5-GFP was predominantly cytosolic, whereas Gyp8-GFP localized to few and bright
punctate structures (Fig. 4A).
Gyp1-GFP that, according to a recent study (34), might be confined to
Golgi compartments labeled smaller and more frequent punctate
structures than Gyp8-GFP. To ascertain this observation, we
co-expressed Gyp1-YFP with Gyp8-CFP and examined the cells by confocal
microscopy. The fluorescence of YFP and CFP was recorded separately. As
shown in Fig. 4B, the structures labeled by Gyp1-YFP and
Gyp8-CFP are obviously not identical, indicating a concentration of at
least part of the two GAPs in different cellular compartments.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 4.
Localization of Gyp-GFP fusion proteins.
A, Gyp-GFP proteins were expressed from pUG23 vector and
visualized by fluorescence microscopy. Nonfluorescent, round areas
represent vacuoles (compare with DIC images). B, Gyp1-YFP
and Gyp8-CFP were coexpressed (see "Experimental Procedures"), and
cells were examined by confocal microscopy. YFP and CFP fluorescence
was recorded separately and merged. Note that Gyp1-YFP (red)
and Gyp8-CFP (green) decorate different structures.
|
|
These analyses show that despite the different abundance of the three
GAPs, each has a typical intracellular localization profile at
steady-state.
Synthetic Growth Inhibition in gyp5 Knockout Strains Expressing a
GTPase-deficient Ypt1 Mutant Protein--
Previous studies have shown
that single deletions of either of the known Ypt-GAP-encoding genes did
not result in clearly observable phenotypes when cells were grown in
rich media. Since Gyp1p, Gyp5p, and Gyp8p are potent Ypt1-GAPs,
we deleted the three chromosomal genes singly and in different
combination in two strains of different genetic background. All mutants
were viable and grew like "wild type"; only the triple
gyp1/
gyp5/
gyp8 deletion in the protease-deficient strain cl3ABYS-86 had a somewhat retarded growth
at low temperature (15 °C) compared with single and double deletion
mutants. We reasoned that if the three GAPs accepted Ypt1p as substrate
also in vivo, specific defects might become apparent when
the GYP genes were deleted in cells that expressed the
GTPase-deficient Ypt1(Q67L) mutant protein. Substitution with leucine
of this highly conserved glutamine, which in Ras is essential for
intrinsic and GAP-accelerated GTP hydrolysis (35), has been reported to
be phenotypically silent in yeast, and this was taken as evidence that
GTP hydrolysis might not be important for Ypt1p function (11). We first
replaced the chromosomal YPT1 gene with the mutant gene
expressing Ypt1(Q67L)p in the haploid strains MSUC-3D and cl3ABYS-86
and found that cell growth of the MSUC-3D(ypt1Q67L)
strain was unaffected at temperatures ranging from 15 to 37 °C,
whereas the protease-deficient strain cl3ABYS-86 did not grow at
15 °C (Fig. 5, A and
B). We then attempted to introduce the ypt1Q67L mutant allele into haploid strains lacking
one or more of the Ypt1-GAP genes. As can be seen from Table
II, the triple deletion of
GYP1, GYP5, and GYP8 precluded
chromosomal exchange of the YPT1 gene by the
ypt1Q67L allele in MSUC-3D, indicating that such
cells are inviable. In cl3-ABYS-86 background, the replacement of
YPT1 by the ypt1Q67L mutant gene was
inefficient when one of the three Ypt1-GAP genes was deleted, and it
was unsuccessful when two of them were deleted. Importantly,
MSUC-3D(ypt1Q67L) cells lacking either the
GYP5 gene alone or GYP5 in combination with
GYP1 or GYP8 displayed a somewhat reduced growth
at suboptimal temperatures (25 or 20 °C) and complete growth
inhibition at 15 °C. For example, the growth rates of the
ypt1Q67L strain and the
ypt1Q67L/
gyp5 strain at 30 °C were
92 and 101 min, and the rates at 20 °C were 195 and 230 min,
respectively. Single deletions of GYP1, GYP8, or
the Ypt7-GAP-encoding GYP7 gene did not affect the growth properties of the MSUC-3D(ypt1Q67L) mutant strain
(Fig. 5A). The consequences of Ypt1-GAP gene deletions were
even more severe in the cl3ABYS-86(ypt1Q67L) strain;
already single knockouts of either GYP5 or GYP8
led to reduced growth at 20 °C. However, regardless of the growth temperature, none of the mutants described above exhibited significant alterations of transport or maturation of newly synthesized secreted invertase or vacuolar carboxypeptidase Y (data not shown).

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 5.
Synthetic growth defects and suppression
analysis of mutant yeast strains. A, serial dilutions
of wild type and different MSUC-3D mutants (genotypes shown to the
right) were grown at different temperatures. B,
the growth of protease-deficient strain cI3-ABYS-86 and the mutant
expressing the ypt1Q67L allele at 15 and 30 °C.
C, high expression of Gyp1p, Gyp5p, and Gyp8p, but not of
Gyp6p or Gyp7p, suppresses the cold-sensitive phenotype of
MSUC-3D(ypt1Q67L/ gyp5/ gyp8).
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Efficiency of YPT1 gene replacement by ypt1Q67L allele in
different strains with Ypt1-GAP gene deletions
Replacement of YPT1 by ypt1Q67L was
verified by PCR analysis followed by digestion with XhoI,
the restriction site being present only in the mutant allele.
|
|
Collectively, these synthetic negative effects suggest a functional
link between the three GAPs and Ypt1p, and they indicate that Gyp5p may
be the most effective GAP for Ypt1p in vivo.
High Intracellular Levels of Ypt1-GAPs Rescue Ypt1(Q67L)-expressing
Mutant Cells from Growth Defects--
As an explanation for the
synthetic growth defects of ypt1Q67L mutant cells
lacking Ypt1-GAP genes, we envisaged the possibility that the intrinsic
GTPase activity of Ypt1(Q67L)p, in contrast to that of the
corresponding Ras mutant protein, was still activable by its cognate
GAPs. In this case, we anticipated that high expression of the
Ypt1-GAPs might rescue ypt1Q67L mutant strains from
growth inhibition at nonpermissive temperature. MSUC-3D(ypt1Q67L/
gyp5/
gyp8),
which does not grow at 15 °C, was transformed with vector pYX212
harboring the Ypt1-GAP gene GYP1, GYP5, or
GYP8 under transcriptional control of the strong TPI
promoter. As controls for Ypt-GAPs with different substrate
specificity, recombinant vectors with either GYP6 (13, 31)
or GYP7 (14, 15) were also used to transform the same mutant strain. As
shown in Fig. 5C, the cold sensitivity of the
ypt1Q67L strain could be suppressed on high
expression of either Gyp1p, Gyp5p, or Gyp8p but not with Gyp6p or Gyp7p.
The results of the suppression analyses suggested that Ypt1(Q67L)p is
in fact a substrate for Ypt1-GAPs. We therefore put the mutant GTPase
to the test for intrinsic and GAP-accelerated GTPase activity. The
intrinsic GTP hydrolysis rate of Ypt1(Q67L)p, followed over a time
course of several hours at 30 °C, was determined to be 6 × 10
5 min
1, which is about 40-fold slower
than that of the wild type protein. Surprisingly, this very slow
intrinsic GTPase activity of Ypt1(Q67L)p could be significantly
accelerated by Gyp5p. Following Michaelis-Menten kinetics, the
kcat for Gyp5-58p was determined to be 0.89 min
1, which corresponds to a 1.5 × 104-fold acceleration of the intrinsic GTP hydrolysis rate
of Ypt1(Q67L)p.
Since the N- and C-terminal regions flanking the GYP domain of Gyp5p
appear to contain several structural domains, we addressed the question
whether these sequence segments are of significance for in
vivo function of this Ypt1-GAP. Various truncation mutants were
tested for their ability to suppress growth inhibition of ypt1Q67L mutant cells (Fig. 1B). It was
found that high expression of the catalytically active fragment lacking
the N-terminal 399 amino acids did not overcome the growth inhibition
at nonpermissive temperature. We then made the observation that on high
expression, this fragment itself was growth-inhibitory unless the
C-terminal end including most of the potential coiled-coil domain
(which comprises amino acids 720-860) was also deleted. Somewhat
surprisingly, this truncation mutant lacking amino acids 2-399 and
760-894 was again active as suppressor. The suppressor activity
depended on the GAP activity of the Gyp5p fragment, since it was lost
when the presumptive "finger arginine" in position 496 was
substituted for alanine or lysine (Fig. 1B).
These results suggest that the Ypt1(Q67L) mutant GTPase is a substrate
for Gyp1p, Gyp5p, and Gyp8p in vivo and that sequences within the N-terminal half of Gyp5p might interact with and neutralize the cell growth-inhibitory effect of the C-terminal 133-amino acid region.
Accumulation of Membrane Material and Alterations Resembling
Autophagic Processes in Mutants Defective in Hydrolysis of Ypt1p-bound
GTP--
Ypt1p is known to have an essential function in ER-to-Golgi
trafficking (7). The most surprising discovery that Ypt1(Q67L)p is a
very efficient substrate at least for one of the Ypt1-GAPs in
vitro is likely to explain the lack of or the very mild growth defects of cells expressing the mutant instead of the wild type Ypt1-GTPase. Because a severe impairment of the hydrolysis of Ypt1p-bound GTP is supposed to shift the GTPase to a permanently active
state, we searched for possible protein transport and morphological alterations in relevant mutant cells. Glycosylation and secretion of
invertase induced in low glucose medium were not significantly affected
either in ypt1Q67L or in
ypt1Q67L/
gyp5 mutant cells. Likewise,
the processing and sorting of vacuolar CPY was not different in mutant
and wild type cells (data not shown).
We next examined, by electron microscopy, cells of strain MSUC-3D and
of its mutant derivatives ADY41(
gyp5),
ADY49(ypt1Q67L), and
ADY51(ypt1Q67L/
gyp5). Cells were grown
at the permissive temperature of 30 °C and fixed with potassium
permanganate to augment membrane structures. The gyp5
deletion strain was not significantly different from wild type. The
ypt1Q67L strain characteristically displayed an
accumulation of vesicular structures about 50-150 nm in size. Cells of
the double mutant showed in addition some proliferation of ER membranes
and, importantly, various alterations of vacuole morphology. In many
cells, vacuoles were fragmented or showed long invaginations resembling
microautophagic tubes (36); others displayed engulfed cytoplasm and
vesicular structures (Fig. 6,
B and D). A number of vacuoles contained round, membrane-bound organelles of about 350 nm that were filled with cytoplasm and membrane material (Fig. 6C). These structures
resembled autophagic bodies, the outer membranes of which were
often partially degraded. Vesicles about 100 nm in size were also
frequently observed in vacuoles (Fig. 6C). The morphological
alterations were even more striking in the proteinase-deficient strain
cl3-ABYS-86. Whereas at the permissive temperature of 30 °C,
gyp5 deletion did not result in a clear phenotype, cells
with the ypt1Q67L mutation (strain ADY29) and
especially the ypt1Q67L/
gyp5 double
mutant cells (strain ADY31) accumulated ER membranes and vesicles of
different size that sometimes formed larger clusters. Typical of the
mutant cells were pleiomorphic vacuole structures; they sometimes had a
club-shaped appearance (Fig. 6E). Vacuoles were mostly
filled with particulate material; some were packed with vesicles
apparently surrounded by two unit membranes. Structures resembling
multivesicular bodies that contained vesicles of 40-50 nm were also
observed (Fig. 6, F-H). Vacuole membranes exhibited several
indentations, and in some cases there were clear indications for direct
uptake of cytoplasmic and membrane material (Fig. 6, F and
H).

View larger version (84K):
[in this window]
[in a new window]
|
Fig. 6.
Morphological alterations of gyp5
deletion strains expressing the ypt1Q67L
mutant allele. Thin section electron microscopy of potassium
permanganate-fixed wild type (A) and mutant
MSUC-3D(ypt1Q67L/ gyp5) cells
(B-D). Accumulation of vesicular structures of different
size and of ER membranes as well as vacuolar inclusions are seen
(A). C, the arrow points to a
structure resembling an autophagosome, and arrowheads point
to vesicules of about 50 nm. D, the arrow points
to a thin vacuolar invagination. E-H, electron micrographs
of protease-deficient
cI3-ABYS-86(ypt1Q67L/ gyp5) mutant
cells. Note the pleiomorphic vacuoles (E) filled with
"vesicles in vesicles" about 100 nm in size (G).
G, the arrow points to an intravacuolar organelle
containing small vesicles and resembling a multivesicular body. The
arrows point to a vesicular structure apparently budding
from the vacuole membrane into the vacuole lumen (F) and to
a tubular appearing organelle apparently in preparation for uptake by
the vacuole (H). Mi, mitochondria; Nu,
nucleus; Va, vacuole. Bars, 1 µM
(B, E); 200 nm (D); 100 nm
(F-H).
|
|
In a first attempt to examine whether an autophagic process caused the
morphological alterations in Ypt1(Q67L)p-expressing cells, we tried to
additionally delete either AUT1 or AUT7, two nonessential genes involved in autophagy (37, 38). Whereas the
knockouts were easily done in MSUC-3D, we were unable to delete either
of the two genes in haploid strains
MSUC-3D(ypt1Q67L/
gyp5) or in
cl3-ABYS-86(ypt1Q67L). Although further
investigations would be required, these results argue for synthetic
negative effects or synthetic lethality. The observed morphological
alterations therefore suggest that the effective blocking of the
hydrolysis of Ypt1p-bound GTP induces previously unnoticed autophagic
processes, most likely to get rid of accumulated membrane material.
 |
DISCUSSION |
In this report, we describe and characterize two novel GAPs that
act on Ypt/Rab GTPases involved in vesicular protein transport. This
brings the GYP family of GTPase-activating proteins in yeast to eight
members. According to our computer search, there appears to be only one
other uncharacterized protein in budding yeast, the open reading frame
of YGL036w, that would satisfy the primary structure criteria
(conserved residues of the GYP domain) for a GAP of this family, but
until now, we have no indication for it having such a biochemical
property. Whereas one of the newly identified GAPs, Gyp5p, has a
remarkable specificity for Ypt1p in vitro, the second,
Gyp8p, exhibits a rather broad substrate specificity like several of
the other yeast Ypt-GAPs that we have studied previously. However,
Ypt1p is also one of the preferred substrate GTPases for Gyp8p in
vitro. The two novel GAPs and the previously identified Gyp1p (18,
34) are the three GYP family members that very efficiently accelerate
the low intrinsic GTP hydrolysis rate of Ypt1p.
One of the puzzling questions is why the deletion of individual GYP
genes, including the newly identified GYP5 and
GYP8, allows yeast cells to survive under normal growth
conditions without any obvious defect in growth or in intracellular
protein transport. One explanation would be that the functional loss of
one GAP can be substituted for by another. This in fact seems to be the
case, although, as shown here, it became apparent only in cells living with the GTPase-deficient Ypt1(Q67L) mutant protein and at less than
optimal growth temperatures. The synthetic negative growth defects of
various mutant combinations in rich media indicates that all
three GAPs, Gyp1p, Gyp5p, and Gyp8p, most likely act on Ypt1p also
in vivo. Evidence for Gyp1p being a Ypt1-GAP has recently
been obtained by Du and Novick (34) who observed various genetic
interactions between this GAP and Ypt1p in synthetic growth media. Our experimental strategy, combining various GYP gene
deletions with the GTPase-deficient Ypt1(Q67L) GTPase uncovered that it is Gyp5p which apparently is the most effective Ypt1-GAP in
vivo.
Additional evidence for Gyp1p, Gyp5p, and Gyp8p acting as Ypt1-GAPs
in vivo comes from our finding that the growth inhibition at
15 °C of a ypt1Q67L/
gyp5/
gyp8
strain (MSUC-3D background) can be overcome specifically by high
intracellular levels of Gyp1p, Gyp5p, and Gyp8p. Interestingly, this is
so although the major fraction of the different GAPs appears to be
located in different cellular compartments. Whereas a recent study (20)
and our own results show that Gyp1p is distributed between the
cytoplasm and punctate structures, apparently representing Golgi
membranes (20), Gyp5p is almost completely cytosolic as demonstrated by
subcellular fractionation and microscopic inspection of cells
expressing a GFP fusion. By confocal microscopy, Gyp8p was primarily
found in a few large structures that did not match the apparent Golgi
compartments with which part of Gyp1p was associated. Since Gyp8p in
high concentration in solution tends to aggregate, it is possible that
the intracellular structures seen with the GFP-Gyp8 fusions represent
aggregates as well. This then might explain why in protease-deficient
cells, high expression of Gyp8p is growth-inhibitory. On the other
hand, Gyp1p and Gyp8p are potent GAPs in vitro not only for
Ypt1p but also for several other Ypt-GTPases. If this were true also
for the situation in living cells, different intracellular localization
of fractions of the two GAPs at steady-state could be the consequence
of their acting at different transport steps.
Since the GTP-loaded Ypt/Rab GTPases are membrane-bound, there should
be a mechanism to recruit the GAPs to those membranes where they are
needed for inactivation of specific substrates. From the fact that a
large part of at least some Ypt/Rab-GAPs can be deleted without
affecting their catalytic potency (18), we previously argued that such
sequences could be important for membrane association of the GAPs. It
was found initially that Gyp5p loses the capability to rescue the
GTPase-deficient ypt1Q67L mutant from growth defect
when it lacks an N-terminal fragment of 400 amino acid residues, which
otherwise is dispensable for catalytic activity and substrate
specificity of this GAP. Although this suggested that the N-terminal
half of Gyp5p is likely to contain sequences required for specific
membrane association, we subsequently discovered that the ability of
the N-terminally truncated Gyp5p to act as suppressor is restored after
further deletion of the C-terminal 135 amino acids including most
of the coiled-coil region. This indicates that the C-terminal sequences with the potential to form coiled-coils might fulfill a noncatalytic function in concert with sequences of the N-terminal half and affect
proper localization and/or catalytic activity. Further functional
analysis of the sequences outside the catalytic domain of Gyp5p would
also be of interest, since previous studies suggested that the protein
product of YPL249c (that we here identify to be the Ypt1-GAP Gyp5p)
appears to interact with Rvs167p, a protein apparently involved in
actin cytoskeleton function (39, 40). In the case of Gyp1p of which a
significant fraction is already bound to membranes, supposedly
including the Golgi, the region N-terminal of the catalytic domain of
Gyp1p is not required to rescue, in synthetic media, a
gyp1 deletion strain from growth inhibition at 37 °C
(34). This might mean that other sequences, perhaps contained in the C
terminus, are used to direct Gyp1p to membranes where it has to act.
However, high expression of the GAPs and their fragments was performed
in the suppression analyses by Du and Novick (34) and in those reported
here. Under these conditions, the level of Ypt1-GAPs at membranes with
the GTP-loaded Ypt1p might be sufficiently high to allow
down-regulation of the GTPase's activity.
The deletion of one or of several of the Ypt1-GAP genes was
phenotypically neutral. We nevertheless assume that the hydrolysis of
Ypt1p-bound GTP is severely inhibited in the
gyp1/
gyp5/
gyp8 triple
deletion mutant, but this has not been investigated. Unless additional
GAPs can act on Ypt1p in vivo, the very mild growth retardation of these mutant cells seems to suggest that the slow inbuilt GTP hydrolytic activity of the essential Ypt1p suffices to
allow ER-to-Golgi traffic to keep cells going under optimal growth
conditions. It is important to note here that in the GTP-bound conformation, small GTPases are generally active. Therefore, under conditions where the hydrolysis of Ypt1p-bound GTP is severely impaired, as for instance in the triple gyp deletion mutant,
one would not necessarily expect deficiencies in ER-to-Golgi traffic, unless GTP hydrolysis would be essential for membrane fusion per se. According to the results of our study, a direct involvement of
Ypt1p in membrane fusion seems unlikely. This is in accord with the
conclusion of a previous analysis in which mutant
Rab5-dependent early endosome fusion occurred in the
absence of hydrolysis of GTPase-bound xanthosine triphosphate (10).
There is ample evidence instead that Ypt/Rab-GTPases could act in the
preparation of membrane fusion by recruiting, to defined membranes,
components required for transport vesicle docking and/or fusion (3, 4,
41).
An unexpected finding of our investigation is that the Ypt1(Q67L)
mutant protein serves as a very efficient substrate for its cognate GAP
Gyp5p. As will be reported elsewhere, this appears not to represent a
special case but rather a general property of Ypt/Rab-GTPases. Marginal
acceleration of the intrinsic GTPase activity of Rab11(Q70L) and
Sec4(Q79L) mutant proteins was also noted previously, although these
investigations had been performed with crude cell extracts as source
for GTPase-activating proteins (42, 43). Our results obtained with
purified Ypt/Rab-GAPs and mutant Ypt/GTPases are in sharp contrast to
mammalian H-Ras protein carrying the equivalent substitution. Ras(Q61L)
is known to be oncogenic (44) because of its significantly reduced
intrinsic GTPase activity, which is not accelerated or is only
marginally accelerated by its cognate GAPs (35, 45). The substitution with leucine of the conserved Gln67 in Ypt1p results in a
40-fold decrease of its inbuilt GTPase activity. This drop of activity
is even more pronounced than that of the corresponding Ras(Q61L) mutant
whose intrinsic GTP hydrolysis rate has been reported to be about
22-fold lower than the hydrolysis rate of wild type H-Ras (46).
Importantly, Gyp5p accelerated the intrinsic GTP hydrolysis rate of
Ypt1(Q67L)p by more than 104-fold, which is even 1000-fold
higher than the intrinsic GTPase activity of wild type Ypt1p.
Therefore, one can assume that there are mechanistic differences in the
mode of activation of GTP hydrolysis by GAPs that are specific for
different GTPase subtypes within the Ras superfamily. The acceptance as
efficient substrate of Ypt1(Q67L)p by its cognate GAP Gyp5p could
explain why cells expressing the GTPase-defective instead of the Ypt1
wild type protein exhibit, depending on the cell's genetic background,
no growth or very minor growth or protein transport alterations. The
same has been reported for Sec4p, the essential GTPase involved
in exocytosis. Sec4(Q79L)p, analogous to Ypt1(Q67L)p, caused cold
sensitivity of mutant cells but only minor lesions of the secretory
activity (43). It is likely, therefore, that in cells expressing
Ypt1(Q67L)p as the only source for Ypt1p there is sufficient hydrolysis
of GTPase-bound GTP to allow cycling and proper functioning of the essential GTPase. In this context, we feel it to be misleading to argue
(11) that GTP hydrolysis is not important for Ypt1-GTPase function in
vesicular transport.
The prominent phenotypes of mutant cells with severely perturbed
hydrolysis of Ypt1p-bound GTP are growth defects at low temperature and
various morphological alterations. The latter were mostly independent
of the growth temperature and included moderately increased
proliferation of ER membranes, pleiomorphic vacuoles, and an
accumulation of vesicular structures of different size, most frequently
ranging from about 50 to 200 nm. Although we have not attempted to
isolate and further examine these membrane-enclosed structures, we feel
it to be likely that they could represent ER-derived vesicles and their
homotypic fusion products. In yeast, COPII-coated transport vesicles
originating from the ER have, on average, a diameter of 50 nm (2).
Several early secretory mutants accumulate this type of vesicle (47),
among them conditional ypt1 mutants at the nonpermissive
temperature (48). In the mutant cells described here, which lack
Ypt1-GAPs and express the GTPase-deficient Ypt1(Q67L) protein as the
only source for Ypt1p, the vast majority of the essential GTPase is
expected to be in its GTP-bound (i.e. active) conformation.
This might lead to increased fusion activity similar to that seen in
mammalian cells that overexpress the corresponding Rab5(Q79L) mutant
GTPase and, as a consequence, form significantly enlarged early
endosomes (49). Increased fusion, therefore, might not only occur
between ER-derived vesicles and Golgi compartments but also between
vesicles themselves. Homotypic COPII vesicle fusion seems to be a
regular event in mammalian cells, giving rise to the formation of
so-called vesicular-tubular clusters (VTCs) (50, 51).
Accelerated and malcontrolled fusion processes that we assume to
take place in mutants with permanently active Ypt1-GTPase obviously do
not impair protein transport from the ER to and through the Golgi but
rather the equilibrium between membrane-enclosed organelles of the
early secretory pathway. The morphological alterations seen in these
cells suggest to us that an autophagic response might be induced,
presumably to destroy transport vesicles and organelles derived from
increased vesicle fusion processes. Vacuolar uptake of vesicular
structures was documented most dramatically in protease-deficient cells
that lack the Ypt1-GAP Gyp5p and express the Ypt1(Q67L)
GTPase. This would resemble pexophagy and mitophagy, the selective
degradation in vacuoles of peroxisomes or mitochondria in response to
changed nutrient and growth conditions (52). The long tubular
invaginations of vacuoles and the apparently direct engulfment and
uptake of vesicular and short tubular organelles from the vacuole
surface seen in the mutants studied here conspicuously resemble the
microautophagic sequestration of peroxisomes, for example (53).
Selective vacuolar sequestration of transport intermediates has not
been observed previously. It is possible, therefore, that induction of
autophagy is a way to not only selectively destroy unused peroxisomes
or mitochondria but also a surplus of organelles of the biosynthetic
pathway to keep the dynamic balance of membranes making up its
different compartments. However, definite proof for a selective
degradation of vesicular transport intermediates via an autophagic
pathway has to await further studies involving different autophagic
mutants, but preliminary results already suggest that haploid cells
expressing the Ypt1(Q67L) mutant GTPase do not allow the deletion of
the otherwise nonessential AUT1 (37) or AUT7 (38) genes.
 |
ACKNOWLEDGEMENTS |
We thank Ursula Welscher-Altschäffel
for technical assistance, Stefan Jakobs for help with the confocal
fluorescence microscopy, Hans Dieter Schmitt for help and discussions,
and Ingrid Balshüsemann for secretarial help.
 |
FOOTNOTES |
*
This work was supported by the Max Planck Society and by
grants from the Deutsche Forschungsgemeinschaft, the Human Frontier Science Program, and Fonds der Chemischen Industrie (to D. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: European Institute of Oncology, Dept. of
Experimental Oncology, Milan 20141, Italy.
§
To whom correspondence should be addressed. Tel.: 49-551-201-1496;
Fax: 49-551-201-1718; E-mail: dgallwi1@gwdg.de.
¶
Present address: Institute of Radiation and Cell Research,
Versbacher Str. 5, D-97078 Würzburg, Germany.
Published, JBC Papers in Press, August 19, 2002, DOI 10.1074/jbc.M205783200
2
Z. Luo and D. Gallwitz, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
SNARE, soluble
N-ethylmaleimide-sensitive factor attachment protein
receptor;
GAP, GTPase-activating protein;
ER, endoplasmic reticulum;
HPLC, high performance liquid chromatography;
GFP, green fluorescent
protein;
CFP, cyan fluorescent protein;
YFP, yellow fluorescent
protein;
P10, pellet after 10,000 × g centrifugation;
P100, pellet after 100,000 × g centrifugation (high
speed pellet);
VSV, vesicular stomatitis virus.
 |
REFERENCES |
| 1.
|
Mellman, I.,
and Warren, G.
(2000)
Cell
100,
99-112[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Barlowe, C.,
Orci, L.,
Yeung, T.,
Hosobuchi, M.,
Hamamoto, S.,
Salama, N.,
Rexach, M. F.,
Ravazzola, M.,
Amherdt, M.,
and Schekman, R.
(1994)
Cell
77,
895-907[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Guo, W.,
Sacher, M.,
Barrowman, J.,
Ferro-Novick, S.,
and Novick, P.
(2000)
Trends Cell Biol.
10,
251-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Zerial, M.,
and McBride, H.
(2001)
Nat. Rev. Mol. Cell. Biol.
2,
107-117[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Cao, X. C.,
Ballew, N.,
and Barlowe, C.
(1998)
EMBO J.
17,
2156-2165[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Wickner, W.,
and Haas, A.
(2000)
Annu. Rev. Biochem.
69,
247-275[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Lazar, T.,
Gotte, M.,
and Gallwitz, D.
(1997)
Trends Biochem. Sci.
22,
468-472[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Cao, X. C.,
and Barlowe, C.
(2000)
J. Cell Biol.
149,
55-65[Abstract/Free Full Text]
|
| 9.
|
Bourne, H. R.,
Sanders, D. A.,
and McCormick, F.
(1990)
Nature
348,
125-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Rybin, V.,
Ullrich, O.,
Rubino, M.,
Alexandrov, K.,
Simon, I.,
Seabra, C.,
Goody, R.,
and Zerial, M.
(1996)
Nature
383,
266-269[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Richardson, C. J.,
Jones, S.,
Litt, R. J.,
and Segev, N.
(1998)
Mol. Cell. Biol.
18,
827-838[Abstract/Free Full Text]
|
| 12.
|
Will, E.,
Albert, S.,
and Gallwitz, D.
(2001)
Methods Enzymol.
329,
50-58[Medline]
[Order article via Infotrieve]
|
| 13.
|
Strom, M.,
Vollmer, P.,
Tan, T. J.,
and Gallwitz, D.
(1993)
Nature
361,
736-739[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Vollmer, P.,
and Gallwitz, D.
(1995)
Methods Enzymol.
257,
118-128[Medline]
[Order article via Infotrieve]
|
| 15.
|
Vollmer, P.,
Will, E.,
Scheglmann, D.,
Strom, M.,
and Gallwitz, D.
(1999)
Eur. J. Biochem.
260,
284-290[Medline]
[Order article via Infotrieve]
|
| 16.
|
Neuwald, A. F.
(1997)
Trends Biochem. Sci.
22,
243-244[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Albert, S.,
and Gallwitz, D.
(2000)
Biol. Chem.
381,
453-456[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Albert, S.,
Will, E.,
and Gallwitz, D.
(1999)
EMBO J.
18,
5216-5225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Albert, S.,
and Gallwitz, D.
(1999)
J. Biol. Chem.
274,
33186-33189[Abstract/Free Full Text]
|
| 20.
|
Du, L. L.,
Collins, R. N.,
and Novick, P. J.
(1998)
J. Biol. Chem.
273,
3253-3256[Abstract/Free Full Text]
|
| 21.
|
Li, B. J.,
and Warner, J. R.
(1998)
Yeast
14,
915-922[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Guldener, U.,
Heck, S.,
Fiedler, T.,
Beinhauer, J.,
and Hegemann, J. H.
(1996)
Nucleic Acids Res.
24,
2519-2524[Abstract/Free Full Text]
|
| 23.
|
De Antoni, A.,
and Gallwitz, D.
(2000)
Gene (Amst.)
246,
179-185[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Schmitt, H. D.,
Puzicha, M.,
and Gallwitz, D.
(1988)
Cell
53,
635-647[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
| Deleted in proof
|
| 26.
|
Benli, M.,
Doring, F.,
Robinson, D. G.,
Yang, X.,
and Gallwitz, D.
(1996)
EMBO J.
15,
6460-6475[Medline]
[Order article via Infotrieve]
|
| 27.
|
Niedenthal, R. K.,
Riles, L.,
Johnston, M.,
and Hegemann, J. H.
(1996)
Yeast
12,
773-786[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Wagner, P.,
Hengst, L.,
and Gallwitz, D.
(1992)
Methods Enzymol.
219,
369-387[Medline]
[Order article via Infotrieve]
|
| 29.
|
Duggleby, R. G.,
and Clarke, R. B.
(1991)
Biochim. Biophys. Acta
1080,
231-236[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Schweins, T.,
Geyer, M.,
Kalbitzer, H. R.,
Wittinghofer, A.,
and Warshel, A.
(1996)
Biochemistry
35,
14225-14231[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Will, E.,
and Gallwitz, D.
(2001)
J. Biol. Chem.
276,
12135-12139[Abstract/Free Full Text]
|
| 32.
|
Rak, A.,
Fedorov, R.,
Alexandrov, K.,
Albert, S.,
Goody, R. S.,
Gallwitz, D.,
and Scheidig, A. J.
(2000)
EMBO J.
19,
5105-5113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Ahmadian, M. R.,
Stege, P.,
Scheffzek, K.,
and Wittinghofer, A.
(1997)
Nat. Struct. Biol.
4,
686-689[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Du, L. L.,
and Novick, P.
(2001)
Mol. Biol. Cell
12,
1215-1226[Abstract/Free Full Text]
|
| 35.
|
Frech, M.,
Darden, T. A.,
Pedersen, L. G.,
Foley, C. K.,
Charifson, P. S.,
Anderson, M. W.,
and Wittinghofer, A.
(1994)
Biochemistry
33,
3237-3244[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Muller, O.,
Sattler, T.,
Flotenmeyer, M.,
Schwarz, H.,
Plattner, H.,
and Mayer, A.
(2000)
J. Cell Biol.
151,
519-528[Abstract/Free Full Text]
|
| 37.
|
Schlumpberger, M.,
Schaeffeler, E.,
Straub, M.,
Bredschneider, M.,
Wolf, D. H.,
and Thumm, M.
(1997)
J. Bacteriol.
179,
1068-1076[Abstract/Free Full Text]
|
| 38.
|
Lang, T.,
Schaeffeler, E.,
Bernreuther, D.,
Bredschneider, M.,
Wolf, D. H.,
and Thumm, M.
(1998)
EMBO J.
17,
3597-3607[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Bon, E.,
Recordon-Navarro, P.,
Durrens, P.,
Iwase, M.,
Toh-e, A.,
and Aigle, M.
(2000)
Yeast
16,
1229-1241[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Tong, A. H. Y.,
Drees, B.,
Nardelli, G.,
Bader, G. D.,
Brannetti, B.,
Castagnoli, L.,
Evangelista, M.,
Ferracuti, S.,
Nelson, B.,
Paoluzi, S.,
Quondam, M.,
Zucconi, A.,
Hogue, C. W. V.,
Fields, S.,
Boone, C.,
and Cesareni, G.
(2002)
Science
295,
321-324[Abstract/Free Full Text]
|
| 41.
|
Pfeffer, S. R.
(1999)
Nat. Cell Biol.
1,
E17-E22[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Casanova, J. E.,
Wang, X. Y.,
Kumar, R.,
Bhartur, S. G.,
Navarre, J.,
Woodrum, J. E.,
Altschuler, Y.,
Ray, G. S.,
and Goldenring, J. R.
(1999)
Mol. Biol. Cell
10,
47-61[Abstract/Free Full Text]
|
| 43.
|
Walworth, N. C.,
Brennwald, P.,
Kabcenell, A. K.,
Garrett, M.,
and Novick, P.
(1992)
Mol. Cell. Biol.
12,
2017-2028[Abstract/Free Full Text]
|
| 44.
|
Barbacid, M.
(1987)
Annu. Rev. Biochem.
56,
779-827[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Brownbridge, G. G.,
Lowe, P. N.,
Moore, K. J.,
Skinner, R. H.,
and Webb, M. R.
(1993)
J. Biol. Chem.
268,
10914-10919[Abstract/Free Full Text]
|
| 46.
|
Krengel, U.,
Schlichting, L.,
Scherer, A.,
Schumann, R.,
Frech, M.,
John, J.,
Kabsch, W.,
Pai, E. F.,
and Wittinghofer, A.
(1990)
Cell
62,
539-548 |